Separation Systems for Commercial Biotechnology

September 26, 2011

Wellesley, Mass. – In a recent release, SEPARATION SYSTEMS FOR COMMERCIAL BIOTECHNOLOGY (BIO011E) from BCC Research (www.bccresearch.com), the global market for commercial biotechnology separation systems totaled $14.4 billion in 2011, and is expected to hold a value of nearly $26.7 billion in 2016, increasing at a five-year compound annual growth rate (CAGR) of 13.1%.

The global market for biotech separation systems can be broken down into 10 segments – liquid chromatography, membrane filtration, flow cytometry, protein microarray, DNA microarray, electrophoresis, centrifugation, lab-on-a-chip, biochips, and magnetic separations.

The liquid chromatography segment held a value of $2.5 billion in 2011, and is expected to increase at a CAGR of 9.6% to reach nearly $4 billion in 2016.

The membrane filtration segment held a value of nearly $3 billion in 2011, and is expected to increase at a CAGR of 4.9 % to reach nearly $3.8 billion in 2016.

The flow cytometry segment held a value of $1.9 billion in 2011, and is expected to increase at a CAGR of 14% to reach $3.7 billion in 2016.

The protein microarray segment was worth $2 billion in 2011, and in 2016 is expected to be worth $5.9 billion, increasing at a CAGR of 23.9%.

The DNA microarray segment was worth nearly $1.5 billion in 2011, and in 2016 is expected to be worth nearly $3.6 billion, increasing at a CAGR of 19%.

The electrophoresis segment was valued at $1.4 billion in 2011 and should be worth $2.3 billion in 2016, a CAGR of 9.9%.

The centrifugation segment held a value of nearly $1.2 billion in 2011, and in 2016 should be worth almost $1.5 billion, a CAGR of 5%.

The lab-on-a-chip segment, worth $420 million in 2011, should be worth $1.1 billion in 2016, increasing at a CAGR of 21.7%.

The segment made up of biochips was worth $175 million in 2011 and in 2016 should be worth $357 million, a CAGR of 15.3%.

The segment made up of magnetic separations was worth $313 million in 2011 and in 2016 should be worth $505 million, a CAGR of 10%.

The biomolecule separation market is positioned for significant growth in the next five years due to new protein and other biomolecule products that will require separation technology, as well as new innovations in the technology itself. This report investigates one of the major drivers for the separations system market, the development of proteins by the biomedical and pharmaceutical industry that can be used as biotherapeutic agents against certain human diseases. Another growth factor that will drive the market is the recognition of separations technology in emerging markets such as Japan and other parts of the Asia-Pacific region.

This report is an invaluable tool for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investors, investor consultants, and anyone interested in the biomolecule separation market, its products, its industry participants, and its future.

To Contact us, click here  

Separation Systems for Commercial Biotechnology( BIO011E )
Publish Date: Sep 2011    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.